bluebird bio Inc (BLUE)
0.4775
+0.01
(+2.47%)
USD |
NASDAQ |
Nov 04, 12:56
bluebird bio Price to Book Value: 1.748 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.706 |
| October 31, 2024 | 1.698 |
| October 30, 2024 | 1.789 |
| October 29, 2024 | 1.80 |
| October 28, 2024 | 1.810 |
| October 25, 2024 | 1.758 |
| October 24, 2024 | 1.827 |
| October 23, 2024 | 1.876 |
| October 22, 2024 | 1.851 |
| October 21, 2024 | 1.818 |
| October 18, 2024 | 1.796 |
| October 17, 2024 | 1.781 |
| October 16, 2024 | 1.763 |
| October 15, 2024 | 1.761 |
| October 14, 2024 | 1.842 |
| October 11, 2024 | 1.852 |
| October 10, 2024 | 1.811 |
| October 09, 2024 | 1.810 |
| October 08, 2024 | 1.783 |
| October 07, 2024 | 1.905 |
| October 04, 2024 | 2.086 |
| October 03, 2024 | 1.896 |
| October 02, 2024 | 1.783 |
| October 01, 2024 | 1.723 |
| September 30, 2024 | 1.901 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.846 |
| September 26, 2024 | 1.821 |
| September 25, 2024 | 1.750 |
| September 24, 2024 | 1.83 |
| September 23, 2024 | 1.789 |
| September 20, 2024 | 1.721 |
| September 19, 2024 | 1.801 |
| September 18, 2024 | 1.812 |
| September 17, 2024 | 1.830 |
| September 16, 2024 | 2.114 |
| September 13, 2024 | 2.217 |
| September 12, 2024 | 2.101 |
| September 11, 2024 | 2.129 |
| September 10, 2024 | 2.088 |
| September 09, 2024 | 1.970 |
| September 06, 2024 | 1.935 |
| September 05, 2024 | 2.081 |
| September 04, 2024 | 2.050 |
| September 03, 2024 | 2.076 |
| August 30, 2024 | 2.054 |
| August 29, 2024 | 2.168 |
| August 28, 2024 | 2.281 |
| August 27, 2024 | 2.306 |
| August 26, 2024 | 2.563 |
| August 23, 2024 | 2.520 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5576
Minimum
Nov 08 2021
5.074
Maximum
Jan 12 2023
1.608
Average
1.313
Median
Feb 10 2022
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 2.462 |
| Protalix BioTherapeutics Inc | 3.448 |
| Predictive Oncology Inc | 1.107 |
| Spectral AI Inc | -- |
| Vertex Pharmaceuticals Inc | 8.229 |
Price to Book Value Related Metrics
| PS Ratio | 1.336 |
| PEG Ratio | -0.0016 |
| Price | 0.4775 |
| Earnings Yield | -464.9% |
| Market Cap | 92.59M |
| PEGY Ratio | -0.0016 |